Dan Hammer Health LTD
Eliminating Heart Disease Naturally Thru Nitric Oxide Therapy
  • Blog
  • The ProArgi-9+ Difference
    • Quality Assurance Standards
    • Testimonials
    • 2009 High Desert Heart Institute Study
    • 2013 Chicago Sky Study
  • Store
    • Products
    • Become a Preferred Customer
    • Shopping Cart
    • Log In
  • Resources
    • Nitric Oxide Therapy
    • Optimize Performance
    • Wellness Library
  • The Million Lives Project
  • About

Archive for CoVid19

Update on CoVid19 and Endothelial Health

Posted by Dan Hammer //
 05/01/2021
update-on-covid19-and-endothelial-health

As more and more research is being done on the CoVid19 virus, one of the areas of focus has been on the lining of the vascular system.

This lining is called the endothelium.

It’s only one-cell thick. But it actually regulates most of your cardiovascular health.

To give you an idea how large this tissue is, there is approximately 60,000 miles to the average vascular system. This includes all your arteries, veins, and capillaries. Lining all of this is the endothelium. If you took it out, and laid the endothelium on the ground, it would cover the surface area of a football field.

That’s a lot of surface volume.

(If you would prefer to view this information in a video format, then please click on my YouTube video below:)

Dr. William Li, who is a vascular biologist and the founder of the Angiogenesis Foundation, compared the endothelium to a freshly resurfaced ice skating rink before a hockey game. Smooth ice that allows the players and puck to glide smoothly.

However, the CoVid19 virus has an effect on the enthelium. In Dr. Li words,

“When the virus damages the inside of the blood vessel and shreds the lining, that’s like the ice after a hockey game. You wind up with a situation that is really untenable for blood flow.”

Dr. Li and his researchers came to this conclusion when they compared the lung tissues of people who died from CoVid19 to those who died from influenza. CoVid19 patients had nine times as many tiny blood clots when compared to influenza patients. And the endothelial lining of the blood vessels of the lungs were severely injured.

A normally functioning endothelium helps to: Read More →

CoVid19 and Endothelial Health

Posted by Dan Hammer //
 11/08/2020
CoVid19 and Endothelial Health

My daughter sent me an article from NPR that talks about CoVid19 and endothelial health. The title of the article is “Clots, Strokes And Rashes. Is COVID-19 A Disease Of The Blood Vessels?”

As more and more research is being done on the CoVid19 virus, one of the areas of focus has been the lining of the vascular system.

This lining is call the endothelium.

It’s only one-cell thick. But it actually regulates most of your cardiovascular health.

To give you an idea how large this tissue is, there is approximately 60,000 miles to the average vascular system. This includes all your arteries, veins, and capillaries. Lining all of this is the endothelium. If you took it out and laid the endothelium on the ground it would cover the surface area of a football field.

That’s a lot of surface volume.

Dr. William Li, who is a vascular biologist and the founder of the Angiogenesis Foundation, compared the endothelium to a freshly resurfaced ice skating rink before a hockey game. Smooth ice that allows the players and puck to glide smoothly.

However, the CoVid19 virus has an effect on the enthelium. In Dr. Li words,

“When the virus damages the inside of the blood vessel and shreds the lining, that’s like the ice after a hockey game. You wind up with a situation that is really untenable for blood flow.”

Dr. Li and his researchers came to this conclusion when they compared the lung tissues of people who died from CoVid19 to those who died from influenza. CoVid19 patients had nine times as many tiny blood clots when compared to influenza patients. And the endothelial lining of the blood vessels of the lungs were severely injured.

A normally functioning endothelium helps to: Read More →

CoVid19 and Vitamin D Deficiency

Posted by Dan Hammer //
 05/08/2020
CoVid19 and Vitamin D Deficiency

There is emerging research that is beginning to link CoVid19 and Vitamin D deficiency. The purpose of this article to to examine this emerging research. And to clarify the level of vitamin D in the blood stream that might present a risk, as well as a benefit.

First, some background on vitamin D.

In nature there are two forms of vitamin D. Vitamin D2 is found in plants and is called ergocalciferol. This form is hard for the human body to convert into an active compound. Because of this vitamin D3 is a better source.

Vitamin D3 is found in animals and is called cholecalciferol.

By themselves both forms are inactive. Our bodies have to convert them to an active compound. This is usually done by the liver and then the kidneys.

Your liver converts vitamin D3 to 25-hydroxycholecalcifoerol, which is then convert by your kidneys into 25-dihydroxycholecalciferol. This final conversion is what is measured in your blood serum. A simple blood test can determine is you fall into one of the following three categories for 25-dihydroxycholecalcifoerl:

  • Normal – would be 30 ng/ml or higher

  • Insufficient – would be 21 – 29 ng/ml

  • Deficiency – would be 20 ng/ml or less

A 2011 study of the US population found that 41.6% of adults are vitamin D deficient. But when viewed based on ethnicity the following was discovered:

  • 69.2% of Hispanics were vitamin D deficient

  • 82.1% of African-Americans were vitamin D deficient

This might be a significant factor in CoVid19 and vitamin D deficiency being a greater issue in the Black population groups. As well as Hispanics having a high risk when compared to the general population.

Now before we look at some of the emerging scientific articles, let’s briefly summarize why vitamin D might be so important in the CoVid19 health crisis. Read More →

CoVid-19 and Hydroxychloroquine

Posted by Dan Hammer //
 04/01/2020
CoVid-19 and Hydroxychloroquine

Over the last month there has been a lot of discussion regarding CoVid-19 and hydroxychloroquine, the drug used for malaria, lupus, and rheumatoid arthritis.

As the CoVid-19 virus spread across the world some nations and governments have been using this drug to treat their patients.

But it wasn’t until President Trump brought it up, at one of the Health Task Force news conferences, that this drug came to national attention here in America.

And the reaction to President Trump linking CoVid-19 and hydroxychloroquine as been mixed.

While President Trump has been extremely enthusiastic about the potential of this drug to save lives, the news media has not. Here are some of their March headlines when President Trump first mentioned this drug:

Why President Trump is at odds with his medical experts over using malaria drugs against Covid-19

Click Here to read the article

Malaria Drug Chloroquine No Better Than Regular Coronavirus Care, Study Finds

Click Here to read the article

There’s scant evidence so far for chloroquine as a COVID-19 drug — but there’s already a shortage

Click Here to read the article

And it continues even today with the news media bashing President Trump, and those who support his position, about the medical use of hydroxychloroquine for CoVid-19.

I thought it would be helpful to cut through the headlines, and agendas, and try to get to the facts about CoVid 19 and hydroxychloroquine. Whether it’s effective in helping people with this deadly virus or not.

Just recently the FDA has given an emergency-use authorization to chloroquine-based products to expand access to these drugs during the CoVid-19 health crisis. This emergency-use authorization allows patients with CoVid-19 to have discussions with their attending physicians about using these types of drugs to treat their illness.

While this doesn’t mean that the chloroquine-based drugs will prove to be effective, it does mean that there is enough information to cause the FDA and the Health Task Force to see this as a potential help in the prevention and recovery from this deadly virus.

Here are three headlines from scientific journals regarding the use of this drug for the treatment of CoVid-19:

Results from a Controlled Trial of Hydroxychloroquine for COVID-19

This study came out of Renmin Hospital of Wuhan University in Wuhan, China. It was a randomized study of 62 patients with half receiving a placebo and the other half taking 200 mg of hydroxychloroquine twice per day for 5 days.

According to Dr. Zhan Zhang, one of the lead researchers, “The data in this study revealed that after 5 days of hydroxychloroquine treatment, the symptoms of patients with COVID-19 were significantly relieved, manifesting as shorten(ing) in the recovery time for cough and fever.”

Those taking the hydroxychloroquine had a return to normal body temperature and cessation of cough one day faster then those in the placebo group.

It has been reported in the news that 4 patients had adverse results during the study. This is true but the 4 patients were in the placebo group.

UW treating COVID-19 patients with antimalarial drug — researcher calls it ‘very promising’

Researchers and physicians at the University of Washington in Seattle have been treating patients with CoVid-19 with hydroxychloroquine. According to Professor Rodney Ho, “There are certain stages of this disease when the drug may be helpful.” But he acknowledges that more research needs to be done in this area.

Which brings me to the final headline:

Penn Launches Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19

The Perelman School of Medicine at the University of Pennsylvania is launching three trials to examine:

  1. If hydroxychloroquine reduces hospital time.

  2. If hydroxychloroquine reduces recover time at home

  3. If hydroxychloroquine can help prevent medical workers from contracting the disease.

We’ll have to wait for these trials to conclude to see if this drug can be effective in the treatment and prevention of CoVid-19.

CoVid-19 and hydroxychloroquine will continue to get attention from both the news media and the medical profession. One thing is clear. It has potential. And that potential needs to be discussed between the patient and the treating physician.

Before I close I’ll leave you with a recent interview conducted by Dr. Oz regarding this controversy

U.S. Doctor Shares New Results Of How Covid-19 Patients Are Doing On Hydroxychloroquine

Hopefully this information will help you and your loved ones have a better understanding of this drug. Especially if anyone gets infected with the CoVid-19 virus and needs medical attention.

Blessing Lives Through Nitric Oxide Therapy!

Dan Hammer

Dan Hammer Health LTD | Copyright © 2025 All Rights Reserved

Powered by WordPress | Customized by Patrick